British Biotech
British based Biotechnology company
British Biotech was a British-based biotechnology company founded as British Biotechnology Limited in 1986 by former G D Searle managers Keith McCullagh and Brian Richards.
It was the first British biotech company to be publicly listed when it was floated on 1 July 1992.
Controversy
In 1996, despite having no compounds on or near the market, the company was temporarily valued at nearly $2.5 billion, largely on the basis of its two main development drugs: marimastat (a novel matrix metalloprotease inhibitor for cancer treatment) and lexipafant (Zacutex, for pancreatitis). Batimastat (codename BB94) progressed as far as stage 3 in its clinical trial, although not orally bioavailable, there are other methods of administration, including transdermal.
In February 1998, Dr Andrew Millar was dismissed as Head of Clinical Research and went on to make allegations that "the Board were running a business plan consistent only with extreme and unfounded optimism". These events were the subject of an inquiry by the House of Commons Select Committee on Science and Technology in August 1998 which absolved Dr Millar of any responsibility for the company's problems.
Subsequent investigations by the Securities and Exchange Commission, Food and Drug Administration, London Stock Exchange and the European Medicines Evaluation Agency found that British Biotech had wilfully misled the public about the progress of marimastat and that unblinding data before the end of clinical trials does not necessarily invalidate the results. Marimastat underwent Phase III trials in collaboration with Schering-Plough Corporation.
Further development of Zacutex was abandoned due to poor clinical trial results.
The corporate politics behind the downfall of British Biotech was later recorded for a BBC2 Series Blood on the Carpet.
Begin with the source’s own compact description: “British Biotech” is british based Biotechnology company. The dossier treats that line as a proposition to test through British, Biotech and based, not as a finished interpretation.
Why this record matters
The phrase “british based Biotechnology company” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
Chronology, provenance and viewpoint should be read together before a broad social or political interpretation is accepted. The source revision retrieved here is dated Aug 27, 2026. The linked authority identifier is Q16241012. 1 of 1 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 1986, 1992, 1996 and 1998.
Official terminology may obscure informal participation, dissent or communities documented only indirectly. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Compare institutional narratives with records created by participants and affected communities. Dates and formal titles are useful anchors, but not substitutes for context.
- Event chronology
- Institutional context
- Locating named record creators
Contemporary correspondence, government or organizational records, oral histories and cited historical scholarship.
Three-step research path
- Establish the record: confirm the title “British Biotech”, its source revision and the description used here.
- Expand the search: follow British Biotech primary sources, British Biotech archive and British research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “British Biotech”?
- Who created the surviving record, and for what administrative purpose?
- Which voices are present, absent or mediated by the institution?
Search terms from this dossier
This entry incorporates text from “British Biotech” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.